This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Will Purcell

The diamond and specialty minerals stocks box score for Thursday was a mediocre 69-61-160 as the TSX Venture Exchange fell three points to 955. Dr. Stewart Blusson's Archon Minerals Ltd. (ACS), down four cents to 11 cents on 14,000 shares when it last traded on Sept. 9, continues to twiddle its corporate thumbs while it awaits potential royalties from the Buffer kimberlites at the Ekati mine in the Northwest Territories. Unfortunately, unless rough diamond prices increase sharply, it could be a long wait. (Shareholders are prepared to wait: Archon sat with 11 cents on the bid all day, but with 24 cents on the ask.)

There is news from Archon -- in other words, another three months have passed since the company's last quarterly report. (In fact, it was five months of silence, as this is also Archon's annual report for fiscal 2025, which ended on May 31.) Normally, Archon's quarterly blurbs are a waste of time, as nearly all the information would be cut and pasted from earlier versions -- frequently without any attempt to alter the dates to make it appear current. This year, however, there have been some meaningful changes.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS